-transparent.png){kind=logo}
A patient treated with anticonvulsants showed hypocalcemia and hyperphosphatemia in association with increased serum parathyroid hormone, reduced serum 25-hydroxy D3, diminished response in phosphorus excretion to exogenous parathyroid hormone and normal response in cyclic AMP excretion. Oral administration of Vitamin D3 resulted in normalization of serum 25-hydroxy D3, calcium, and phosphorus. At this stage, phosphorus excretion after parathyroid hormone returned to normal. These findings suggest that the patient had pseudohypoparathyroidism type II with anti-convulsant medication as a complicating factor.
Related Publications
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
May 2002,
Clinical pediatrics,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
January 1982,
Metabolic bone disease & related research,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
November 1981,
Indian pediatrics,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
November 1980,
The Journal of clinical endocrinology and metabolism,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
December 1978,
The Kobe journal of medical sciences,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
January 1975,
Archives francaises de pediatrie,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
September 2005,
Clinical calcium,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
February 2012,
BMJ case reports,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
January 2010,
Journal of clinical research in pediatric endocrinology,
I Matsuda, and
Y Takekoshi, and
M Tanaka, and
N Matsuura, and
B Nagai, and
Y Seino
August 1972,
Proceedings of the Royal Society of Medicine,
